EirGenix provides not just technology services but integral solutions that you can rely on.
Eirgenix develops high quality biologic products, advancing an extensive pipeline of candidates to improve the lives of patients.
EirGenix Achieves The Fourth Milestone Of Its Trastuzumab Biosimilar Licensing Agreement
Hong Hai/Foxconn Founder Terry Guo Announces Investment To Accelerate EirGenix’s Global Expansion
Positive Phase III Clinical Results for EirGenix’s Proposed Trastuzumab Biosimilar
EirGenixは日本市場を拡大するために、日本の会社と長期供給契約の締結について
Our facility is located in Taiwan, and offers the service to clients around the world.
